• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通肝素和低分子量肝素对凝血及血小板与细胞外基质黏附的抑制作用

Inhibition of coagulation and platelet adhesion to extracellular matrix by unfractionated heparin and a low molecular weight heparin.

作者信息

Krupinski K, Basic-Micic M, Lindhoff E, Breddin H K

机构信息

Department of Hematology, Medical School, Bialystok, Poland.

出版信息

Blut. 1990 Nov;61(5):289-94. doi: 10.1007/BF01732879.

DOI:10.1007/BF01732879
PMID:2176900
Abstract

In 7 healthy volunteers, the effect of a single i.v. injection of 52 mg (7,500 IU) of an unfractionated heparin (UFH) and of 52.5 mg (5,000 anti XaU) of a low molecular weight heparin (LMWH) on coagulation parameters and platelet function has been studied. Thrombin-induced platelet aggregation was inhibited after the injection of both heparins. There was no significant change of ADP or collagen-induced aggregation after LMWH of UFH. Platelet adhesion to bovine extracellular matrix was not inhibited by UFH but was significantly reduced after addition in vitro and ex vivo after administration of LMWH. Further investigation should establish the time course of LMWH effects on platelet adhesion. A long duration of this effect could be partially correlated with the antithrombotic effects of LMWH.

摘要

在7名健康志愿者中,研究了单次静脉注射52毫克(7500国际单位)普通肝素(UFH)和52.5毫克(5000抗Xa单位)低分子肝素(LMWH)对凝血参数和血小板功能的影响。注射两种肝素后,凝血酶诱导的血小板聚集均受到抑制。注射LMWH或UFH后,ADP或胶原诱导的聚集无显著变化。UFH不抑制血小板与牛细胞外基质的黏附,但在体外添加以及LMWH给药后体内外添加后,血小板与牛细胞外基质的黏附显著降低。进一步的研究应确定LMWH对血小板黏附作用的时间进程。这种作用的长时间持续可能与LMWH的抗血栓作用部分相关。

相似文献

1
Inhibition of coagulation and platelet adhesion to extracellular matrix by unfractionated heparin and a low molecular weight heparin.普通肝素和低分子量肝素对凝血及血小板与细胞外基质黏附的抑制作用
Blut. 1990 Nov;61(5):289-94. doi: 10.1007/BF01732879.
2
Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesion.普通肝素和低分子量肝素对血小板诱导的凝血酶形成时间及血小板黏附的影响。
Semin Thromb Hemost. 1993;19 Suppl 1:22-8.
3
[Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs].[普通肝素和低分子量肝素对犬血小板聚集及体外出血时间的影响]
Dtsch Tierarztl Wochenschr. 1999 Oct;106(10):439-44.
4
Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.抗凝糖胺聚糖诱导犬的出血时间延长与凝血酶诱导的血小板聚集受抑制有关。
Thromb Res. 2003;112(1-2):83-91. doi: 10.1016/j.thromres.2003.10.005.
5
Effects of bemiparin, dalteparin, and unfractionated heparin on platelet interaction with human subendothelium under flow conditions.贝米肝素、达肝素和普通肝素在流动条件下对血小板与人内皮下组织相互作用的影响。
J Pharmacol Sci. 2008 May;107(1):103-6. doi: 10.1254/jphs.08018sc.
6
Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects.健康受试者中阿昔单抗或替罗非班与普通肝素或低分子量肝素相互作用的药效学特征。
Br J Clin Pharmacol. 2001 Sep;52(3):297-305. doi: 10.1046/j.0306-5251.2001.01446.x.
7
Platelet aggregation in humans and nonhuman primates: relevance to xenotransplantation.人类和非人类灵长类动物的血小板聚集:与异种移植的相关性。
Xenotransplantation. 2012 Jul-Aug;19(4):233-43. doi: 10.1111/j.1399-3089.2012.00712.x.
8
Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood.帕米普明,一种低分子量肝素,可防止人全血中血小板 - 白细胞聚集体的P - 选择素依赖性形成。
Thromb Haemost. 2007 Jun;97(6):965-73. doi: 10.1160/th06-12-0680.
9
Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography.未分级肝素和低分子肝素对血小板减少全血凝固的影响:应用血栓弹力描记术的体外研究。
Blood Coagul Fibrinolysis. 2021 Jul 1;32(5):305-311. doi: 10.1097/MBC.0000000000001023.
10
Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action.普通肝素和低分子量肝素对血管内组织因子途径抑制物的不同作用:抗血栓作用存在差异的证据
Br J Haematol. 1998 Jun;101(4):638-46. doi: 10.1046/j.1365-2141.1998.00770.x.

本文引用的文献

1
Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina.血小板与培养的内皮细胞产生的细胞外基质的相互作用:一种研究分离的内皮下基膜血栓形成性的模型。
Thromb Res. 1982 Oct 15;28(2):179-91. doi: 10.1016/0049-3848(82)90260-2.
2
In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions.
Thromb Haemost. 1981 Oct;46(3):612-6.
3
Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously.皮下注射两种低分子量肝素的抗凝作用。
Thromb Res. 1983 Nov 15;32(4):381-91. doi: 10.1016/0049-3848(83)90091-9.
4
Effect of heparin on platelet aggregation.
Am J Hematol. 1984 Oct;17(3):295-306. doi: 10.1002/ajh.2830170310.
5
Antithrombotic actions and pharmacokinetics of heparin fractions and fragments.
Nouv Rev Fr Hematol (1978). 1984;26(4):267-75.
6
Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.肾上腺素以及肾上腺素与二磷酸腺苷联合作用对人血小板纤维蛋白原受体的诱导作用。
J Biol Chem. 1980 Nov 25;255(22):10971-7.
7
Effect of heparin and heparin fractions on platelet aggregation.
J Clin Invest. 1980 Jan;65(1):64-73. doi: 10.1172/JCI109661.
8
Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function.普通肝素与低分子肝素类似物对血小板功能影响的比较。
Br J Clin Pharmacol. 1984 Jan;17(1):43-8. doi: 10.1111/j.1365-2125.1984.tb04997.x.
9
The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo.肝素在体内外对血小板聚集和黏附的增强作用。
Clin Sci Mol Med. 1973 Oct;45(4):485-94. doi: 10.1042/cs0450485.
10
Plasma heparin: a unique, practical, submicrogram-sensitive assay.血浆肝素:一种独特、实用、对亚微克敏感的检测方法。
J Lab Clin Med. 1973 Feb;81(2):298-310.